¿À°æ¹Ì ¸íÀÇ

µ¿¾çÀÎÀÇ ÆíµÎÅë Æ¯Â¡ ¿¬±¸

¿À°æ¹Ì ¸íÀÇ

  • ¼Ò ¼Ó
    °í·Á´ëÇб³ ±¸·Îº´¿ø ½Å°æ°ú
  • Àü¹®ºÐ¾ß
    ³úÁ¹Áß,³úÇ÷°ü Áúȯ,µÎÅë

ÁÖ¿ä Áø·á ºÐ¾ß´Â ³úÁ¹Áß, ³ú°æ»ö, µÎÅëÀÌ¸ç °í´ë ±¸·Îº´¿ø ³ú½Å°æ¼¾ÅÍ¿¡¼­ µÎÅë Ŭ¸®´ÐÀ» ¿î¿µÇϰí ÀÖ´Ù.
ÆíµÎÅëÀÇ ´Ù¾çÇÑ Áõ»ó Áß ¼­¾çÀΰú´Â ´Ù¸¥ µ¿¾çÀθ¸ÀÇ Æ¯Â¡À» ã°í ÀÖÀ¸¸ç, ÆíµÎÅë ±Þ¼º±â Ä¡·á¿Í »îÀÇ Áú °³¼±À» À§ÇÑ ¿¹¹æÄ¡·á ¹× ¸¸¼ºÈ­ ¹æÁö¸¦ À§ÇÑ ¸ÞÄ¿´ÏÁòÀ» ¿¬±¸Çϰí ÀÖ´Ù. ¶ÇÇÑ, ÆíµÎÅë Ä¡·á¾à¹°¿¡ ´ëÇÑ ¿©·¯ ±¹Á¦ ÀÓ»ó½ÃÇè¿¡ Âü¿©Çϰí ÀÖ´Ù.

¸íÀÇÇÁ·ÎÇÊ ¸íÀÇ ÇÁ·ÎÇÊ

ÇзÂ

Educational Background
  • °í·Á´ë ÀÇ´ë Çлç
  • °í·Á´ë ÀÇ´ë ¼®»ç
  • °í·Á´ë ÀÇ´ë ¹Ú»ç

ÁÖ¿ä°æ·Â

Work Experience
  • úÞ) °í·Á´ëÇб³ ±¸·Îº´¿ø ½Å°æ°ú ±³¼ö

ÇÐȸȰµ¿

Academic activities
  • ´ëÇѳúÁ¹ÁßÇÐȸ Á¤È¸¿ø
  • ´ëÇѵÎÅëÇÐȸ Æò»ýȸ¿ø
  • ´ëÇѽŰæ°úÇÐȸ Á¤È¸¿ø
Àú¼­ ¾ÆÀÌÄÜ

ÁýÇÊÀú¼­

ÃÑ 0°Ç
¿¬±¸ ¾ÆÀÌÄÜ

ÁÖ¿ä³í¹®

ÃÑ 7°Ç
Á¦ ¸ñ Impact of in-hospital COVID-19 quarantine policy changes on quality of acute stroke care: a single center experience
¹ßÇ¥³âµµ 2025. 01 ¹ßÇ¥Áö Frontiers in Neurology
Á¦ ¸ñ Long-Chain Polysaturated Fatty Acid in Atrial Fibrillation-Associated Stroke: Lipidomic-GWAS Study
¹ßÇ¥³âµµ 2024. 12 ¹ßÇ¥Áö Thrombosis and Haemostasis
Á¦ ¸ñ Perfusion Imaging-Based Triage for Acute Ischemic Stroke: Trends in Use and Impact on Clinical Outcomes
¹ßÇ¥³âµµ 2024. 09 ¹ßÇ¥Áö Stroke: Vascular and Interventional Neurology
Á¦ ¸ñ Sarcopenia is a predictor for Alzheimer¡¯s continuum and related clinical outcomes
¹ßÇ¥³âµµ 2024. 09 ¹ßÇ¥Áö Scientific Reports
Á¦ ¸ñ High glycated albumin is associated with early neurological deterioration in patients with acute ischemic stroke
¹ßÇ¥³âµµ 2024. 08 ¹ßÇ¥Áö BMC Neurology
Á¦ ¸ñ Ethnic differences in the effects of apolipoprotein E ɛ4 and vascular risk factors on accelerated brain aging
¹ßÇ¥³âµµ 2024. 07 ¹ßÇ¥Áö Brain Communications
Á¦ ¸ñ Predicting cerebrovascular age and its clinical relevance: Modeling using 3D morphological features of brain vessels
¹ßÇ¥³âµµ 2024. 06 ¹ßÇ¥Áö Heliyon

¸íÀÇqna ¸íÀÇ QnA

Q °¡Àå °ü½É ÀÖ´Â ºÐ¾ß¿Í ¾÷ÀûÀÌ ÀÖ´Ù¸é ¾Ë·ÁÁÖ¼¼¿ä

ÆíµÎÅë / ÆíµÎÅë ±Þ¼º±â Ä¡·á¿Í »îÀÇ Áú °³¼±À» À§ÇÑ ¿¹¹æÄ¡·á ¹× ¸¸¼ºÈ­ ¹æÁö¸¦ À§ÇÑ ¸ÞÄ¿´ÏÁòÀ» ¿¬±¸Çϰí ÀÖ´Ù. ¶ÇÇÑ, ÆíµÎÅë Ä¡·á¾à¹°¿¡ ´ëÇÑ ¿©·¯ ±¹Á¦ ÀÓ»ó½ÃÇè¿¡ Âü¿©Çϰí ÀÖ´Ù.

Q ȯÀÚ Áø·á¿¡ ÀÖ¾î °¡Àå Áß¿äÇÏ°Ô »ý°¢ÇÏ´Â °¡Ä¡´Â?

ȯÀÚÀÇ »îÀÇ Áú °³¼±

Q ȯÀڵ鿡°Ô ÀüÇÏ°í ½ÍÀº ¸»¾¸

ÁúȯÀ» ÀÌÇØÇÏ°í Æ÷±âÇÏÁö ¾Ê°í ÀÇ»ç¿Í ÇÔ²² Ä¡·á¿¡ Âü¿©ÇÏ¸é ¹Ýµå½Ã ´õ ³ªÀº »îÀ» »ì ¼ö ÀÖ½À´Ï´Ù.

¸íÀÇqna ¸íÀÇ ¼Ò¼Óº´¿ø

°í·Á´ëÇб³ ±¸·Îº´¿ø

»ó±ÞÁ¾ÇÕº´¿ø
ÀüÈ­ ¾ÆÀÌÄÜ ´ëÇ¥¹øÈ£
02-2626-1114
À¥»çÀÌÆ® ¾ÆÀÌÄÜȨÆäÀÌÁö

ÁÖ¿ä½Ã¼³

ÀÀ±Þ½Ç ÀÀ±Þ½Ç
Ŭ¸®´Ð Ŭ¸®´Ð
Á¾ÇÕ°ËÁø¼¾ÅÍ Á¾ÇÕ°ËÁø¼¾ÅÍ
¾Ï¼¾ÅÍ ¾Ï¼¾ÅÍ
ÁÖÂ÷½Ã¼³ ÁÖÂ÷½Ã¼³

°í·Á´ëÇб³ ±¸·Îº´¿øÀº 1983³â ÀÇ·á ¼Ò¿Ü Áö¿ªÀÇ ÀÇ·á º¹Áö¸¦ ½ÇÇöÇϰڴٴ ¸ñÇ¥·Î ¼³¸³µÈ ÀÌÈÄ ´ëÇк´¿øÀÇ »ç¸íÀ» ´ÙÇϸç Áø·á, ±³À°, ¿¬±¸ 3´ë ÇÙ½É ºÐ¾ß¿¡¼­ ºñ¾àÀûÀ¸·Î ¹ßÀüÇß½À´Ï´Ù. ±Ç¿ª ³» ÃÖ»óÀ§ ÀÇ·á±â°üÀ¸·Î¼­ ÁßÁõȯÀÚ Äɾ À§ÇÑ Àü¹æÀ§ ½Ã½ºÅÛÀ» °®Ãß°í ÀÖÀ¸¸ç ƯÈ÷ ¾Ïº´¿ø, ±Ç¿ªÀÀ±ÞÀÇ·á¼¾ÅÍ, Àü±¹ À¯ÀÏÀÇ ÁßÁõ¿Ü»óÀü¹®ÀǼö·Ã¼¾ÅÍ, º¸°Çº¹ÁöºÎ ÁöÁ¤ °íÀ§Çè»ê¸ð¡¤½Å»ý¾ÆÅëÇÕÄ¡·á¼¾ÅÍ, ¼­¿ï ¼­ºÎ±Ç¿ª À¯ÀÏ Áö¿ªÀǾàǰ
¾ÈÀü¼¾ÅÍ µîÀ» ¿î¿µÇÏ¸ç ´ëÇѹα¹ ´ëÇ¥ »ó±ÞÁ¾ÇÕº´¿øÀ¸·Î¼­ÀÇ ¿ªÇÒÀ» Ãæ½ÇÈ÷ ¼öÇàÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¿¬±¸Á߽ɺ´¿øÀ¸·Î¼­ ±â¼ú »ç¾÷È­¿¡¼­µµ µÎ°¢À» ³ªÅ¸³»¸ç ¼­¿ïÁö¿ª À¯ÀÏÀÇ '°³¹æÇü½ÇÇè½Ç'°ú 'Çõ½ÅÇü ÀÇ»ç°úÇÐÀÚ °øµ¿¿¬±¸»ç¾÷' ÁÖ°ü±â°üÀ¸·Î ¼±Á¤µÇ´Â µî ¹ÙÀÌ¿À¸ÞµðÄà ±â¼ú ¿ª·® °­È­¿¡µµ ¾ÕÀå¼­°í ÀÖ½À´Ï´Ù.

°í·Á´ëÇб³ ±¸·Îº´¿ø À̹ÌÁö

¼­¿ïƯº°½Ã ±¸·Î±¸ ±¸·Îµ¿·Î 148

Ȩ
³»°¡ ¾Ë°íÀÖ´Â ¸íÀǸ¦ ÃßÃµÇØÁÖ¼¼¿ä